Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 887 | 47,955 | 11,734 | 2,920 | 9,977 |
| Gross Profit | 887 | 47,955 | 11,734 | 2,920 | 9,977 |
| Operating Expenses | 66,369 | 72,663 | 77,285 | 89,522 | 80,181 |
| Operating Income | -65,482 | -24,708 | -65,551 | -86,602 | -70,204 |
| Interest Expense | 48 | 57 | 44 | 54 | 51 |
| Other Income | 4,877 | 5,876 | 6,700 | 7,473 | 8,414 |
| Pre-tax Income | -60,653 | -18,889 | -58,895 | -79,183 | -61,841 |
| Income Tax | 172 | 1,265 | 205 | -231 | -1,087 |
| Net Income Continuous | -60,825 | -20,154 | -59,100 | -78,952 | -60,754 |
| Net Income | $-60,825 | $-20,154 | $-59,100 | $-78,952 | $-60,754 |
| EPS Basic Total Ops | -0.87 | -0.29 | -0.85 | -1.14 | -0.88 |
| EPS Basic Continuous Ops | -0.87 | -0.29 | -0.85 | -1.14 | -0.88 |
| EPS Diluted Total Ops | -0.87 | -0.29 | -0.85 | -1.14 | -0.88 |
| EPS Diluted Continuous Ops | -0.87 | -0.29 | -0.85 | -1.14 | -0.88 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.29 | -0.85 | -1.14 | -0.88 |
| EBITDA(a) | $-64,353 | $-23,372 | $-63,795 | $-84,906 | $-68,570 |